{{Drugbox
| IUPAC_name               = 5-methyl-2-phenyl-2,4-dihydro-3''H''-pyrazol-3-one
| image                    = <!-- can someone add this? thanks -->
| CAS_number               = 89-25-8
| ATC_prefix               = none
| ATC_suffix               = 
| PubChem                  = 4021
| DrugBank                 = 
| ChemSpiderID             = 3881
| C = 10 | H = 10 | N = 2 | O = 1
| molecular_weight         = 174.20 g/mol
| smiles                   = O=C1N(/N=C(\C1)C)c2ccccc2
| synonyms                 = MCI-186
| bioavailability          = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = Rx-only
| routes_of_administration = Oral
}}

'''Edaravone''' ('''Radicut''') is a [[neuroprotective]] [[drug|agent]] used for the purpose of aiding [[neurological]] [[stroke recovery|recovery]] following acute [[brain ischemia]] and subsequent [[cerebral infarction]].<ref name="isbn0-12-040537-7">{{cite book | author = Doherty, Annette M. | title = Annual Reports in Medicinal Chemistry, Volume 37 (Annual Reports in Medicinal Chemistry) | publisher = Academic Press | location = Boston | year = 2002 | pages = | isbn = 0-12-040537-7 | oclc = | doi = | url = http://books.google.com/books?id=fT6NTDby3zUC&lpg=PA265&pg=PA265#v=onepage&q&f=false}}</ref> It acts as a [[potency (pharmacology)|potent]] [[antioxidant]] and strongly [[scavenger (chemistry)|scavenges]] [[free radical]]s, protecting against [[oxidative stress]] and [[neuronal]] [[apoptosis]].<ref name="pmid15049127">{{cite journal | author = Watanabe T, Tanaka M, Watanabe K, Takamatsu Y, Tobe A | title = [Research and development of the free radical scavenger edaravone as a neuroprotectant] | language = Japanese | journal = Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan | volume = 124 | issue = 3 | pages = 99<U+2013>111 | year = 2004 | month = March | pmid = 15049127 | doi = | url = http://joi.jlc.jst.go.jp/JST.JSTAGE/yakushi/124.99?from=PubMed&lang=en}}</ref><ref name="pmid18221078">{{cite journal | author = Higashi Y, Jitsuiki D, Chayama K, Yoshizumi M | title = Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases | journal = Recent Patents on Cardiovascular Drug Discovery | volume = 1 | issue = 1 | pages = 85<U+2013>93 | year = 2006 | month = January | pmid = 18221078 | doi = | url = }}</ref><ref name="pmid16834755">{{cite journal | author = Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N | title = Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury | journal = CNS Drug Reviews | volume = 12 | issue = 1 | pages = 9<U+2013>20 | year = 2006 | pmid = 16834755 | doi = 10.1111/j.1527-3458.2006.00009.x | url = http://dx.doi.org/10.1111/j.1527-3458.2006.00009.x}}</ref> It has been marketed solely in [[Japan]] by [[Mitsubishi Pharma]] since 2001.<ref name="isbn0-12-040537-7">{{cite book | author = Doherty, Annette M. | title = Annual Reports in Medicinal Chemistry, Volume 37 (Annual Reports in Medicinal Chemistry) | publisher = Academic Press | location = Boston | year = 2002 | pages = | isbn = 0-12-040537-7 | oclc = | doi = | url = http://books.google.com/books?id=fT6NTDby3zUC&lpg=PA265&pg=PA265#v=onepage&q&f=false}}</ref>

== References ==
{{Reflist}}


{{Antioxidants}}

[[Category:Antioxidants]]
[[Category:Pyrazolones]]
